WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Intra-Cellular Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 10:14 am Sale | 2023-12-29 | 13G | Intra-Cellular Therapies, Inc. ITCI | WELLINGTON MANAGEMENT CO LLP | 1,763,475 1.830% | -3,646,210 (-67.40%) | Filing |
| 2023-02-06 2:53 pm Purchase | 2022-12-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | WELLINGTON MANAGEMENT CO LLP | 5,409,685 5.710% | 5,409,685 (New Position) | Filing |